WHO to give update on Sinopharm vaccine emergency use listing | Inquirer News
Close  

WHO to give update on Sinopharm vaccine emergency use listing

/ 06:43 PM May 07, 2021
Vaccination against coronavirus disease in Stip

FILE PHOTO: A syringe and a box of China’s Sinopharm coronavirus disease (COVID-19) vaccine are seen at a sport center, as the country continues its mass inoculation campaign, in Stip, North Macedonia May 6, 2021. REUTERS/Ognen Teofilovski

GENEVA — The World Health Organization (WHO) expects news on Friday regarding an emergency use listing for the COVID-19 vaccine made by Chinese state-owned drugmaker Sinopharm, a WHO spokesman said.

“We are kind of expecting an update on the EUL listing for Sinopharm in the next hour or so,” WHO spokesman Christian Lindmeier told a U.N. briefing. Results of its review of the COVID-19 shot made by Sinovac Biotech could come next week, he said.

ADVERTISEMENT

A WHO emergency listing is a signal to national regulators on a product’s safety and efficacy. It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, but which currently faces major supply constraints.

FEATURED STORIES

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, Sinopharm, World Health Organization (WHO)
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.